We are live on
!
Find out more
Lord, Abbett & Co Portfolio holdings
AUM
$30.6B
1-Year Est. Return
57.44%
This Fund
S&P 500
This Quarter
Est. Return
+6.45%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$30.8B
AUM Growth
+$741M
(+2.5%)
Cap. Flow
-$14.8B
Cap. Flow
% of AUM
-47.97%
Top 10 Holdings %
Top 10 Hldgs %
8.31%
Holding
851
New
152
Increased
227
Reduced
305
Closed
99
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$92.3M |
| 2 |
Clorox
CLX
|
+$90.2M |
| 3 |
Universal Health Services
UHS
|
+$86.5M |
| 4 |
American International
AIG
|
+$81.4M |
| 5 |
Corteva
CTVA
|
+$74.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DHR.PRA
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
|
+$13.2B |
| 2 |
Bank of America
BAC
|
+$164M |
| 3 |
DuPont de Nemours
DD
|
+$120M |
| 4 |
Intuitive Surgical
ISRG
|
+$102M |
| 5 |
Johnson & Johnson
JNJ
|
+$93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 14.54% |
| 3 | Financials | 14.22% |
| 4 | Industrials | 11.55% |
| 5 | Consumer Discretionary | 10.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
1-800-Flowers.com
FLWS
$245M
| $6.88M | 0.02% |
364,143
+158,299
| +77% | +$3.02M |
|
577
Rocket Pharmaceuticals
RCKT
$355M
| $6.8M | 0.02% |
453,480
+133,119
| +42% | +$2.32M |
|
578
Itaú Unibanco
ITUB
$92.3B
| $6.75M | 0.02% |
984,951
-192,185
| -16% | -$1.21M |
|
|
XEC
579
DELISTED
CIMAREX ENERGY CO
XEC
| $6.75M | 0.02% |
113,755
-194,821
| -63% | -$12.5M |
|
580
8x8 Inc
EGHT
$262M
| $6.72M | 0.02% |
279,033
-68,872
| -20% | -$1.6M |
|
581
West Pharmaceutical
WST
$23.3B
| $6.45M | 0.02% |
51,500
-46,400
| -47% | -$5.48M |
|
582
CEVA Inc
CEVA
$980M
| $6.35M | 0.02% |
260,947
+34,255
| +15% | +$841K |
|
583
HDFC Bank
HDB
$119B
| $6.33M | 0.02% |
194,588
-66,944
| -26% | -$2.02M |
|
584
Wintrust Financial
WTFC
$10.7B
| $6.27M | 0.02% |
85,723
-178,537
| -68% | -$13M |
|
|
ZEN
585
DELISTED
ZENDESK INC
ZEN
| $6.14M | 0.02% |
+68,971
| New | +$5.93M |
|
586
Q32 Bio
QTTB
$452M
| $6.11M | 0.02% |
17,358
-6,725
| -28% | -$2.64M |
|
|
BDXA
587
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
| $5.93M | 0.02% |
95,813
-163,168
| -63% | -$9.67M |
|
588
Advanced Energy
AEIS
$11.7B
| $5.9M | 0.02% |
+104,780
| New | +$5.61M |
|
589
Scholastic
SCHL
$769M
| $5.43M | 0.02% |
+163,500
| New | +$6.1M |
|
590
Axalta
AXTA
$7.22B
| $5.37M | 0.02% |
180,525
+10,417
| +6% | +$276K |
|
591
Illumina
ILMN
$28.7B
| $5.26M | 0.02% |
14,679
-63,550
| -81% | -$20.1M |
|
592
Marvell Technology
MRVL
$170B
| $5.2M | 0.02% |
217,989
+12,692
| +6% | +$296K |
|
593
Apogee Enterprises
APOG
$855M
| $5.17M | 0.02% |
+119,100
| New | +$4.66M |
|
594
Consolidated Edison
ED
$41.1B
| $5.1M | 0.02% |
58,200
-108,700
| -65% | -$9.36M |
|
595
Moody's
MCO
$84.2B
| $5.05M | 0.02% |
25,875
-52,523
| -67% | -$9.97M |
|
596
Columbia Banking Systems
COLB
$8.74B
| $5M | 0.02% |
+138,202
| New | +$4.89M |
|
|
GNFT
597
DELISTED
Genfit
GNFT
| $4.87M | 0.02% |
246,487
+39,326
| +19% | +$920K |
|
|
CADE
598
DELISTED
Cadence Bancorporation
CADE
| $4.77M | 0.02% |
+229,504
| New | +$4.72M |
|
599
Byline Bancorp
BY
$1.76B
| $4.68M | 0.02% |
244,898
+32,203
| +15% | +$617K |
|
600
Bankunited
BKU
$3.36B
| $4.64M | 0.02% |
+137,507
| New | +$4.74M |
|
Similar funds
Lord, Abbett & Co's Q2 2019 Portfolio in Review
As of Q2 2019, Lord, Abbett & Co held 851 positions worth $30.8B, up 2.5% from $30B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
Lord, Abbett & Co withdrew a net $14.8B in Q2 2019, closing 99 positions and reducing 305 holdings. Its most notable exit was DuPont de Nemours, an estimated $120M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lord, Abbett & Co opened a new position in Dow Inc worth $86.2M.
- Lord, Abbett & Co's largest Q2 2019 buy was Dow Inc: 1,747,600 shares worth $86.2M.
- Lord, Abbett & Co added most to Clorox in Q2 2019, an estimated $90.2M increase.
- Lord, Abbett & Co's biggest Q2 2019 reduction was Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A, cutting an estimated $13.2B.
- Lord, Abbett & Co fully exited DuPont de Nemours in Q2 2019, selling an estimated $120M.
- Lord, Abbett & Co's ten largest holdings make up 8.3% of its $30.8B portfolio in Q2 2019.
- Lord, Abbett & Co opened 152 new positions and closed 99 in Q2 2019.
- Lord, Abbett & Co's portfolio value rose 2.5% quarter-over-quarter to $30.8B.
Based on Lord, Abbett & Co's 13F filing for Q2 2019, filed 14 Aug 2019.